Asset Allocation
| Position | Category/Sector | Target Weight |
|---|---|---|
CCEP.L Coca-Cola Europacific Partners plc | Consumer Defensive | 0.90% |
DRUG Bright Minds Biosciences Inc | Healthcare | 0.93% |
GMEX GMEX Robotics Corporation | Technology | 1.88% |
MNPR Monopar Therapeutics Inc. | Healthcare | 1.33% |
PRU.TO Perseus Mining Limited | Basic Materials | 83.53% |
SEZL Sezzle Inc. Common Stock | Financial Services | 3.90% |
WGS GeneDx Holdings Corp. | Healthcare | 4.94% |
ZIVO ZIVO Bioscience, Inc. | Healthcare | 2.59% |
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Magnum Experiment 28, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.
Loading graphics...
The earliest data available for this chart is Mar 11, 2026, corresponding to the inception date of GMEX
Returns By Period
| 1D | 1M | YTD | 6M | 1Y | 3Y* | 5Y* | 10Y* | |
|---|---|---|---|---|---|---|---|---|
Benchmark S&P 500 Index | -0.11% | 2.16% | -0.42% | 4.03% | 27.10% | 18.38% | 10.55% | 12.70% |
Portfolio Magnum Experiment 28 | -0.25% | -0.02% | — | — | — | — | — | — |
| Portfolio components: | ||||||||
CCEP.L Coca-Cola Europacific Partners plc | 0.43% | -3.53% | 5.72% | 10.58% | 13.51% | 18.27% | 12.81% | 7.30% |
DRUG Bright Minds Biosciences Inc | -2.75% | 15.64% | 7.06% | 32.01% | 189.80% | 233.60% | 33.00% | — |
GMEX GMEX Robotics Corporation | -2.63% | -68.82% | — | — | — | — | — | — |
MNPR Monopar Therapeutics Inc. | -3.18% | -2.64% | -14.12% | -36.14% | 60.73% | 106.70% | 14.86% | — |
PRU.TO Perseus Mining Limited | 0.89% | 6.38% | 11.02% | 32.86% | 88.23% | 39.59% | 36.35% | 29.42% |
SEZL Sezzle Inc. Common Stock | -13.62% | -8.55% | -5.94% | -22.81% | 54.64% | — | — | — |
WGS GeneDx Holdings Corp. | -0.72% | -22.42% | -54.16% | -51.02% | -38.30% | 80.62% | -34.51% | — |
ZIVO ZIVO Bioscience, Inc. | -25.00% | -74.19% | -72.41% | -81.82% | -84.00% | -48.80% | -48.64% | -23.72% |
Monthly Returns
Based on dividend-adjusted daily data since Mar 12, 2026, Magnum Experiment 28's average daily return is -0.16%, while the average monthly return is -1.95%.
Historically, 50% of months were positive and 50% were negative. The best month was Apr 2026 with a return of +5.4%, while the worst month was Mar 2026 at -9.3%. The longest winning streak lasted 1 consecutive months, and the longest losing streak was 1 months.
On a daily basis, Magnum Experiment 28 closed higher 52% of trading days. The best single day was Mar 31, 2026 with a return of +8.0%, while the worst single day was Mar 19, 2026 at -6.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -9.28% | 5.38% | -4.40% |
Expense Ratio
Magnum Experiment 28 has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.
Return for Risk
Return / Risk — by metrics
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.
| Risk / Return Rank | Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Martin ratio | |
|---|---|---|---|---|---|---|
CCEP.L Coca-Cola Europacific Partners plc | 49 | 0.66 | 0.98 | 1.13 | 1.19 | 2.54 |
DRUG Bright Minds Biosciences Inc | 86 | 2.63 | 3.26 | 1.36 | 6.18 | 13.54 |
GMEX GMEX Robotics Corporation | — | — | — | — | — | — |
MNPR Monopar Therapeutics Inc. | 60 | 0.93 | 1.78 | 1.21 | 1.91 | 3.44 |
PRU.TO Perseus Mining Limited | 79 | 2.10 | 2.45 | 1.33 | 3.94 | 11.69 |
SEZL Sezzle Inc. Common Stock | 54 | 0.66 | 1.58 | 1.22 | 1.34 | 1.93 |
WGS GeneDx Holdings Corp. | 18 | -0.45 | -0.13 | 0.98 | -0.46 | -0.96 |
ZIVO ZIVO Bioscience, Inc. | 7 | -0.57 | -0.72 | 0.89 | -0.98 | -2.21 |
Loading graphics...
Dividends
Dividend yield
Magnum Experiment 28 provided a 1.47% dividend yield over the last twelve months.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Portfolio | 1.47% | 1.21% | 1.65% | 1.60% | 1.01% | 0.79% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% | 0.00% |
| Portfolio components: | ||||||||||||
CCEP.L Coca-Cola Europacific Partners plc | 0.03% | 0.03% | 0.03% | 0.04% | 0.04% | 0.03% | 0.02% | 0.03% | 0.03% | 0.05% | 0.56% | 0.03% |
DRUG Bright Minds Biosciences Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GMEX GMEX Robotics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MNPR Monopar Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PRU.TO Perseus Mining Limited | 1.76% | 1.45% | 1.97% | 1.92% | 1.20% | 0.94% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SEZL Sezzle Inc. Common Stock | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
WGS GeneDx Holdings Corp. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ZIVO ZIVO Bioscience, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Magnum Experiment 28. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Magnum Experiment 28 was 18.15%, occurring on Mar 20, 2026. The portfolio has not yet recovered.
The current Magnum Experiment 28 drawdown is 4.40%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -18.15% | Mar 12, 2026 | 7 | Mar 20, 2026 | — | — | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Diversification
Diversification Metrics
Number of Effective Assets
The portfolio contains 8 assets, with an effective number of assets of 1.42, reflecting the diversification based on asset allocation. This number of effective assets suggests a highly concentrated portfolio, where a few assets dominate the allocation, potentially increasing the portfolio's risk due to lack of diversification.
Asset Correlations Table
| Benchmark | ZIVO | CCEP.L | GMEX | WGS | MNPR | SEZL | PRU.TO | DRUG | Portfolio | |
|---|---|---|---|---|---|---|---|---|---|---|
| Benchmark | 1.00 | -0.02 | 0.41 | 0.46 | 0.47 | 0.59 | 0.56 | 0.67 | 0.69 | 0.74 |
| ZIVO | -0.02 | 1.00 | -0.55 | 0.23 | -0.13 | -0.08 | 0.24 | -0.28 | 0.30 | -0.19 |
| CCEP.L | 0.41 | -0.55 | 1.00 | 0.09 | -0.04 | 0.29 | 0.17 | 0.31 | 0.08 | 0.29 |
| GMEX | 0.46 | 0.23 | 0.09 | 1.00 | 0.34 | -0.08 | 0.47 | 0.09 | 0.55 | 0.19 |
| WGS | 0.47 | -0.13 | -0.04 | 0.34 | 1.00 | 0.33 | 0.50 | 0.24 | 0.32 | 0.28 |
| MNPR | 0.59 | -0.08 | 0.29 | -0.08 | 0.33 | 1.00 | 0.31 | 0.38 | 0.49 | 0.39 |
| SEZL | 0.56 | 0.24 | 0.17 | 0.47 | 0.50 | 0.31 | 1.00 | 0.18 | 0.60 | 0.33 |
| PRU.TO | 0.67 | -0.28 | 0.31 | 0.09 | 0.24 | 0.38 | 0.18 | 1.00 | 0.28 | 0.97 |
| DRUG | 0.69 | 0.30 | 0.08 | 0.55 | 0.32 | 0.49 | 0.60 | 0.28 | 1.00 | 0.44 |
| Portfolio | 0.74 | -0.19 | 0.29 | 0.19 | 0.28 | 0.39 | 0.33 | 0.97 | 0.44 | 1.00 |